ArticleBiomedicines2023

Development of a Non-Peptide Angiotensin II Type 1 Receptor Ligand by Structural Modification of Olmesartan as a Biased Agonist.

Yoshino Matsuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.